Login

BVZ Group Half-Year Financials 2019: An Interview with Fernando Lehner, Company Leader | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Reflections on National Security Reporting: Insights from Walter's Journey|Walter Pincus
00:10:00
Exploring Dodge & Cox's Emerging Market Holdings | Diana Strandberg, Director of International equity , Dodge & Cox.
00:10:00
The New York Stock Exchange welcomes UiPath executives and guests to celebrate its Initial Public Offering (NYSE: PATH).
00:10:00
PYX Resources' Export License and Its Role in Strengthening EBITDA | Oliver Hasler, CEO , PYX Resources Ltd.
00:10:00
Connecting Education and Industry at the Northern Ontario Mining Showcase
00:10:00
Grindrod Reports 26% Rise in Earnings, Records Record Port Volumes | Xolani Mbambo - CEO of Grindrod Limited
00:10:00
Introducing Rio de Mar: U.S. Broker-Dealer with a Focus on Institutional Trading and Global Expansion
00:10:00
Dundee's Arsenic Stabilization: Converting Toxic Waste into Safe, Long-Lasting Glass
00:10:00
Antipa: Expanding Gold and Copper Resources in Western Australia
00:10:00
Simplifying Business Valuations for Growth | Brooklyn Brock, Founder, Ellevate Advisors LLC.
00:10:00
A New Beginning: Eric Foss Welcomes Employees at Yosemite | Eric Foss, CEO, Aramark.
00:10:00
Logistics Emerges as Key Driver in South Africa's Economic Recovery Amidst Ecommerce Surge | Steven Brown , CEO, Fortress Real Estate Investments Ltd.

© 2017 - Neuhu+